Lenacapavir: a new treatment of resistant HIV-1 infections

Lancet Infect Dis. 2023 Mar;23(3):286. doi: 10.1016/S1473-3099(23)00075-0.
No abstract available

MeSH terms

  • Anti-HIV Agents* / therapeutic use
  • HIV Infections* / drug therapy
  • HIV-1*
  • Humans

Substances

  • Anti-HIV Agents